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ABSTRACT Sticholysin I and II (St I and St II), two basic cytolysins purified from the Caribbean sea anemone Stichodactyla
helianthus, efficiently permeabilize lipid vesicles by forming pores in their membranes. A general characteristic of these toxins
is their preference for membranes containing sphingomyelin (SM). As a consequence, vesicles formed by equimolar mixtures
of SM with phosphatidylcholine (PC) are very good targets for St I and II. To better characterize the lipid dependence of the
cytolysin-membrane interaction, we have now evaluated the effect of including different lipids in the composition of the
vesicles. We observed that at low doses of either St I or St II vesicles composed of SM and phosphatidic acid (PA) were
permeabilized faster and to a higher extent than vesicles of PC and SM. As in the case of PC/SM mixtures, permeabilization
was optimal when the molar ratio of PA/SM was 1. The preference for membranes containing PA was confirmed by
inhibition experiments in which the hemolytic activity of St I was diminished by pre-incubation with vesicles of different
composition. The inclusion of even small proportions of PA into PC/SM LUVs led to a marked increase in calcein release
caused by both St I and St II, reaching maximal effect at 5 mol % of PA. Inclusion of other negatively charged lipids
(phosphatidylserine (PS), phosphatidylglycerol (PG), phosphatidylinositol (PI), or cardiolipin (CL)), all at 5 mol %, also elicited
an increase in calcein release, the potency being in the order CL PA PG PI PS. However, some boosting effect was
also obtained, including the zwitterionic lipid phosphatidylethanolamine (PE) or even, albeit to a lesser extent, the positively
charged lipid stearylamine (SA). This indicated that the effect was not mediated by electrostatic interactions between the
cytolysin and the negative surface of the vesicles. In fact, increasing the ionic strength of the medium had only a small
inhibitory effect on the interaction, but this was actually larger with uncharged vesicles than with negatively charged vesicles.
A study of the fluidity of the different vesicles, probed by the environment-sensitive fluorescent dye diphenylhexatriene (DPH),
showed that toxin activity was also not correlated to the average membrane fluidity. It is suggested that the insertion of the
toxin channel could imply the formation in the bilayer of a nonlamellar structure, a toroidal lipid pore. In this case, the presence
of lipids favoring a nonlamellar phase, in particular PA and CL, strong inducers of negative curvature in the bilayer, could help
in the formation of the pore. This possibility is confirmed by the fact that the formation of toxin pores strongly promotes the
rate of transbilayer movement of lipid molecules, which indicates local disruption of the lamellar structure.
INTRODUCTION
Sticholysin I and II (St I and St II) are the two most potent
cytolysins purified from the Caribbean sea anemone Sticho-
dactyla helianthus (order Actiniaria). They belong to a
group of highly homologous proteins, characterized by high
pI, molecular size 20 kDa, inhibition by sphingomyelin
(Bernheimer, 1990; Kem, 1988; Macek et al., 1994; Turk,
1991) and predominant  structure (Menestrina et al.,
1999), collectively called actinoporins (Kem, 1988). St I
and St II together constitute 90% of the cytolytic fraction
of the anemone venom (Lanio et al., 2001). They are char-
acterized by a few amino acid substitutions, 13, scattered
throughout the primary sequence, which could in principle
originate a different mechanism of action. Indeed, a differ-
ent lipid dependence has been reported for St I (Tejuca et
al., 1996) and St II (De Los Rios et al., 1998). In addition,
the hemolytic activity of St II is higher than that of St I,
30,000 HU/mg and 21,700 HU/mg, respectively (Lanio et
al., 2001). Both St I and St II, as well as probably all other
actinoporins, exert their cytolytic action by forming oligo-
meric pores in the cell membrane (De Los Rios et al., 1998;
Tejuca et al., 1996), and therefore belong to the large
protein superfamily of pore-forming toxins (PFT).
The interest in these toxins has risen in recent years.
Besides being important envenoming and pathogenic fac-
tors, studied to understand their mode of action, PFT are
also useful for clarifying basic mechanisms such as
polypeptide insertion into membranes, self-aggregation,
pore assembly, and solute permeation through the newly
formed pores (Lacy and Stevens, 1998; Lesieur et al., 1997).
In addition, they are increasingly recognized as attractive
tools for biotechnological and pharmaceutical applications.
They have been used for the construction of antitumoral or
antimicrobial toxins (Al-yahyaee and Ellar, 1996; Panchal
et al., 1996; Pederzolli et al., 1995; Tejuca et al., 1999), for
the selective permeabilization of mammalian cells, allowing
the investigation of diverse cell functions (Ahnert-Hilger
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and Weller, 1997; Bhakdi et al., 1993) or the loading of
foreign molecules (Russo et al., 1997) and, finally, for the
creation of switchable pores that open and close at the
application of different stimuli (Bayley, 1995; Gu et al.,
1999). From this point of view, eukaryotic actinoporins
constitute an interesting alternative to the most studied
prokaryotic PFT, though their molecular mechanism of ac-
tion is still less well understood.
Actinoporins are very potent toxins affecting almost all
kind of eukaryotic cells on which they have been tried
(Macek et al., 1994). The reason for this apparent nonse-
lectivity is that they use sphingomyelin, a lipid that is
ubiquitous in animal cells, as a low-affinity acceptor
(Macek et al., 1995). Exploiting as acceptors certain diffuse
classes of lipids is indeed a common feature in the PFT
family. Examples are cholesterol binding bacterial cytol-
ysins (Alouf and Geoffroy, 1991), the sphingomyelin (SM)-
seeking hemolytic lectin CEL-III of the sea cucumber
(Hatakeyama et al., 1999), and Vibrio cytolysins requiring
both cholesterol and SM (Bhakdi et al., 1993). Besides
being always present, these fundamental components of the
animal cell membrane are particularly enriched in special-
ized micro-regions, called lipid rafts (Edidin, 1997; Rietveld
and Simons, 1998), and this may help the toxin reaching in
those regions a critical concentration necessary for aggre-
gation and pore formation (Fivaz et al., 1999). In addition to
major components, such as phosphatidylcholine (PC), SM,
and cholesterol, cell membranes contain many other lipids,
albeit in lower amounts. Making use of the ability of acti-
noporins to permeabilize model membranes, such as lipid
vesicles, we decided to investigate the role of lipid compo-
sition in this interaction. Permeabilizing effects by St I and
St II were compared to other properties of the different
vesicles prepared, such as size, polydispersity, and fluidity.
Results suggest an important role played by even minor
amounts of phosphatidic acid and cardiolipin, two lipids
inducing negative curvature in bilayers, and suggest that the
tendency of these lipids to induce negative curvature of the
bilayer could be involved in the mechanism of pore forma-
tion.
MATERIALS AND METHODS
Reagents
St I and St II were purified as described (Alvarez et al., 1998; Lanio et al.,
2001) by combining gel filtration chromatography on Sephadex G-50
medium (Amersham-Pharmacia Biotech, Uppsala, Sweden) and ionic ex-
change chromatography on CM-cellulose 52 (Whatman, Maidstone, UK).
Calcein was obtained through Sigma Chemical Co. (Milan, Italy) and
Triton X-100 (Tx100) from Merck (Milan, Italy). Lipids used were egg
phosphatidylcholine (PC), phosphatidylserine (PS), phosphatidic acid
(PA), phosphatidylglycerol (PG), phosphatidylinositol (PI), cardiolipin
(CL), sphingomyelin (SM), phosphatidylethanolamine (PE), stearylamine
(SA), and 1-palmitoyl-2-[6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]ca-
proyl]-sn-glycero-3-phosphocholine (P-C6-NBD-PC). All lipids were pur-
chased from Avanti Polar Lipids (Alabaster, AL), and were 99% pure as
stated by the purchaser.
Preparation of lipid vesicles
Small unilamellar vesicles (SUV) were prepared by thorough sonication of
a multilamellar liposomes suspension in 10 mM Tris-HCl, pH 7.4, as
described earlier (Pazos et al., 1998). Large unilamellar vesicles (LUVs)
were prepared as already described (Tejuca et al., 1996) by extruding a
solution of multilamellar liposomes prepared in the presence of 80 mM
calcein (pH 7.0 adjusted by NaOH), and subjected to six cycles of freezing
and thawing. A two-syringe extruder was used, equipped with two stacked
polycarbonate filters (Nuclepore, Maidstone, UK) with 100-mm holes
(MacDonald et al., 1991). Thirty-one passages were performed each time.
Lipid compositions used are reported in the text. The initial lipid concen-
tration, either with SUV or LUV, was 10 mg/ml. To remove untrapped
calcein, the vesicles were spun through mini-columns (Pierce, Rockford,
IL) loaded with Sephadex G-50 (medium) pre-equilibrated with 100 mM
NaCl, 1 mM EDTA, and 10 mM Tris-HCl, pH 7.4 (elution buffer).
Inhibition of the hemolytic activity of St I
SUV were used for the hemolytic activity inhibition experiments. SUV of
SM, PC/SM (1:1), SM/PA (1:1), or PC were incubated with sticholysins at
different lipid/toxin molar ratio, as indicated in the text, and the remaining
hemolytic activity was assayed by measuring the decrease in the turbidity
of a human red blood cell (HRBC) suspension measured at 420 nm in a
microplate reader (EMS reader NF, version 2.4). Human red blood cells
were prepared from pooled fresh human total blood obtained from healthy
volunteers as already described (Tejuca et al., 1996).
Vesicle permeabilization
This was determined by measuring the fluorescence of released calcein
with a fluorescence microplate reader (Fluostar from SLT, Austria). Flu-
orescence was excited through a narrow band interference filter centered at
485 nm and was detected after a second filter at 538 nm. White plastic
96-well microplates (Labsystems Fluoroplate, Helsinki, Finland) were pre-
treated with 0.1 mg/ml Prionex (Pentapharm, Switzerland) which strongly
reduces unspecific binding of protein and vesicles to plastic (Dalla Serra et
al., 1999). Each well was filled with the elution buffer plus the desired
amount of LUV (between 1 and 5 M depending on lipid composition).
Finally, toxin was added, in a total volume of 200 l, at the concentration
reported in the text. After mixing vesicles and toxin, the release of calcein
produced an increase in fluorescence, F (due to the dequenching of the dye
into the external medium) which was resolved in time. Each reported value
is the average of five consecutive readings of the same well (taken at room
temperature in 0.5 s). Spontaneous leakage of calcein was negligible under
these conditions. Maximum release was always obtained by adding 1 mM
Tx100 (final concentration) and provided the fluorescence value Fmax. The
percentage of release R(%) was calculated as follows:
R% Ffin Fin/Fmax Fin 100 (1)
where Fin and Ffin represent the initial and the final (steady-state) value of
fluorescence before and after toxin addition.
In the experiments with variable ionic strength the buffer composition
was as follows: x  626 mM NaCl, (1  x)  1252 mM sucrose, 1 mM
EDTA, and 10 mM Tris-HCl, pH 7.4, with x ranging from one to zero. In
this way the osmolarity of the solution was kept constant while varying the
ionic strength. Vesicles were pre-equilibrated in this solution for at least 15
min before adding the toxin.
Fluorescence polarization measurements
Diphenylhexatriene (DPH) fluorescence polarization measurements were
carried out in a photon counting spectrofluorimeter (Spex Fluoromax,
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Edison, NJ) using excitation wavelength 358 nm (5-nm slit) and emission
wavelength 427 nm (5-nm slit). Polarization (P) was measured using two
Glan-Thompson quartz polarizers and was determined as follows (Lakow-
icz, 1983):
P Ivv G  Ivh/Ivv G  Ivh (2)
G Ihv/Ihh (3)
where I is the observed fluorescence intensity and the first of the two
subscripts refers to the position of the excitation polarizer, the second to
that of the emission polarizer, v stands for vertical, and h for horizontal
(defined with respect to the optical plane). G is a correction factor intro-
duced to compensate for the different optical transmission of the apparatus
with vertically and horizontally polarized light (Lakowicz, 1983). Mea-
sured G was typically 1.06  0.01. DPH was diluted at 50 nM in elution
buffer from a concentrated stock solution and vesicles were added at a final
lipid concentration of 20 M.
Measurement of vesicles size by photon
correlation spectroscopy
LUV size was determined by photon correlation spectroscopy (as in Mayer
et al., 1986) at a fixed angle (90°) and room temperature, using a laser
particle sizer (Malvern Z-sizer 3, Malvern, UK) equipped with a 5-mW
He-Ne laser. Lipid concentration was in the range between 2 and 20 g/ml.
A 64-channel correlator was used which can provide particle size estimates
in the range from 5 to 5000 nm. Data were analyzed by the cumulant
method using Malvern Application Software. The first cumulant provides
the apparent diffusion coefficient of the vesicles from which the hydrody-
namic radius 	R
 can be derived through the Stokes-Einstein relation
(Pecora, 1985; Santos and Castanho, 1996). Distribution width was calcu-
lated from the second cumulant, as reported in (Santos and Castanho,
1996).
Determination of the rate of lipid flip-flop
in vesicles
The transbilayer movement of a short-chain fluorescent lipid, P-C6-NBD-
PC, was measured by mixing labeled LUVs with bovine serum albumin
(BSA). Selective extraction of the labeled lipid by BSA was detected via
the decrease in fluorescence due to quenching caused by BSA (Marx et al.,
2000). P-C6-NBD-PC (0.25 mol %) was incorporated into PC/SM (1:1)
LUV before their extrusion as above. Extruded LUVs, at 125 M lipid,
were mixed with 400 g/ml BSA in elution buffer. The time course of
NBD fluorescence emission intensity was measured with the Spex Fluoro-
max instrument (ex 470 nm, slit 1 nm, em 530 nm, slit 1 nm) with an
integration time of 1 s per point.
RESULTS
Inhibition of sticholysin hemolytic activity by
vesicle of different composition
Previous results of our and other laboratories have shown
that pre-incubation of actinoporins with lipid SUV inhibits
their hemolytic activity. SM was the most effective lipid in
this respect. However, associations of this lipid with other
components have not been thoroughly studied. We have
now compared the remaining hemolytic activity of St I after
pre-incubation with SUV of SM, or PC/SM (1:1), or SM/PA
(1:1), or only PC (Fig. 1). SM/PA (1:1) vesicles caused the
largest inhibition of St I hemolysis, followed by SM, and
PC/SM, whereas PC vesicles practically did not cause any
inhibition.
Clearly, vesicles that do not contain SM are poor targets
for St I, as it was earlier demonstrated for this (Tejuca et al.,
1996) and for other actinoporins (Bernheimer and Avigad,
1976; Macek et al., 1994). However, the inclusion with SM
of 50% PA promoted a higher inhibition than inclusion of
the same proportion of PC, suggesting a stronger interaction
of the protein with vesicles containing a high proportion of
this negatively charged phospholipid. We decided to study
this effect further, using a direct assay of vesicle permeabi-
lization.
Effect of vesicle composition on the
permeabilizing activity of St I and St II
Addition of St I to a solution containing calcein-loaded
LUV promoted the release of the dye to a different rate and
extent depending on the lipid composition (Fig. 2 A). St I
and St II are differentiated by 13 amino acid substitutions,
scattered throughout the primary sequence, which could in
principle originate a different mechanism of action (see, for
example, some differences reported for the action of St I and
St II in Tejuca et al., 1996 and De Los Rios et al., 1998,
respectively, and the different specific hemolytic activity
FIGURE 1 Inhibition of St I hemolytic activity by pre-incubation with
vesicles of different composition. The time course of hemolysis was followed
via the decrease in turbidity of a human red blood cell suspension initially
adjusted to an apparent absorbance of 0.1 OD at   420 nm. The toxin was
applied either directly or after 30 min of pre-incubation with SUV composed
of PC, PC/SM (1:1), SM, SM/PA (1:1) (as indicated), at a lipid/protein molar
ratio of 833. The curve with PC SUVwas virtually identical to the control with
the same dose of cytolysin, but not pre-incubated with the lipid (not shown).
Toxin concentration was always 6 nM.
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(Lanio et al., 2001)). Therefore, we thought that compar-
ing the effects of these two toxins could be important,
and in most of the rest will report data obtained with both
molecules. Dose-dependence curves of maximal release
with LUV of different compositions are shown in Fig. 2,
B and C, for St I and St II, respectively. For vesicles that
do not contain SM little or no release was observed, even
at high protein concentrations. Vesicles containing SM
instead showed a substantial release depending on both
the type and the proportion of the other lipid in the
mixture. When the various lipid compositions are com-
pared at a low toxin dose, it becomes apparent that
SM/PA were more susceptible than SM/PC mixtures,
being permeabilized faster and to a higher extent. In
addition, lipids mixed in a 1:1 molar ratio showed a
higher release than either the single components or most
of the nonequimolar mixtures (Fig. 2 and Table 1). Re-
sults with St I and St II were similar.
Because the morphological features of vesicles compris-
ing such different components might vary substantially, we
characterized them by analyzing their size and fluidity using
photon correlation spectroscopy (Fig. 3) and DPH fluores-
cence polarization, respectively. Indeed, important varia-
tions of both parameters were observed. Results are sum-
marized and compared to permeabilization parameters in
Table 1. Although the dimensions of vesicles composed of
pure PC or PA, or the PC/SM and PC/PS mixtures, were all
100 nm diameter (as expected from the size of the pores
used to extrude them), and the dispersity of the sample was
very small (SD  20 nm), with other compositions this was
not always true. The most dramatic deviation was observed
for vesicles of pure SM, which appeared to have an average
diameter of1000 nm and a high polydispersity (SD 700
nm), suggesting the persistence of a high proportion of
multilamellar vesicles.
In view of this, the reduced calcein release observed with
SM vesicles may be in part caused by the fact that not all of
the inner vesicle compartments are accessible, because St I
cannot cross the outer bilayer and reach the internal ones.
Nonetheless, this can only be part of the reason, as the
observed release was very low, implying that not even the
outermost layer was permeabilized. In fact, previous studies
on the permeabilization of SM/PC LUV by St I showed a
decrease of activity when the amount of SM was increased
from 50% to 75% (Tejuca et al., 1996), an effect that was
essentially due to a reduced binding.
SM/PA LUV had also larger sizes (between 250 and 330
nm) and a somewhat higher polydispersity (75 nm  SD 
160 nm, see Table 1); therefore, the fact that with these
LUVs maximal release saturated 50% instead of 80%, as
with PC/SM, should probably be ascribed to the presence of
a certain proportion of oligolamellar structures. Also, in this
case release was higher with the mixtures than with the
single components. The same is true also for PC/PA vesi-
cles, which had a similar distribution of sizes, and for which
FIGURE 2 Permeabilizing effects of St I and St II on vesicles of differ-
ent composition. (A) Kinetics of release at a small constant dose of St I (6.4
nM) with different lipid compositions. Solid lines are single-exponential
relaxations. Vesicles were composed of PC, SM, and PA either as single
components or as binary combinations, as indicated (here and in the other
panels, the curve with PA alone was superimposed on that of PC alone and
was omitted for clarity). Lipid concentration was always 2 M. Buffer
solution was 100 mM NaCl, 1 mM EDTA, and 10 mM Tris-HCl, pH 7.4.
(B and C) Dose-dependence of the maximal release induced by St I (B) or
St II (C) derived from the steady state of kinetic traces like those in A.
Points are average  SEM of 10 determinations for PC/SM (1:1), of two
determinations for SM/PA (1:1) and PC, and single values for the others.
Solid lines have no theoretical meaning.
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a small but detectable release was observed only for the
equimolar mixture. Results with St I and St II were quali-
tatively similar, as shown by the evaluated parameters re-
ported in Table 1.
The role of PA in St I and St II
permeabilizing activity
Because PA, and other negatively charged lipids, are mainly
concentrated in the inner leaflet of cell membranes and are
present only in very small proportions in the outer layer
(Connor et al., 1989; Gascard et al., 1991; Langner and
Kubica, 1999; Op den Kamp, 1979), we decided to inves-
tigate whether PA could have a relevant role in toxin action
even at lower, more physiological, concentrations. For this
reason we took vesicles composed of PC/SM in a 1:1 molar
ratio, as it occurs in many mammalian cells, and added
increasing amounts of PA (up to 10 mol %). As reported in
Table 2, all these vesicles had homogeneous size (diameter
ranging from 110 to 130 nm), and quite narrow polydisper-
sity (15 nm  SD  24 nm). Interestingly, addition of PA
to such PC/SM vesicles elicited a detectable effect on sti-
cholysin activity already at a dose of 0.2 mol %, (Fig. 4 and
Table 2). Differences were most evident in C50 (i.e., the
toxin concentration needed to reach 50% of maximal effect)
and in the permeabilization rate. The time course of calcein
release induced by St I (and also St II) was reasonably
described by a single time constant, 	 (Fig. 4 A). From this
we obtained a permeabilization rate, k  1/	, whose depen-
dence on cytolysin concentration and vesicles composition
is shown in Fig. 4 C. The exponent of the dose dependence
and the association constant were derived for both St I and
St II (see Appendix) and included in Table 2. The boosting
effect of PA was proportional to its amount, becoming
maximal at 5 mol %. Because such small proportions are
FIGURE 3 Determination of average size and distribution of LUV of
different composition by photon correlation spectroscopy obtained as de-
scribed in the Methods section. Results for the LUV compositions used in
Fig. 2 are shown. Values for all compositions used in this paper were
measured in the same way and are reported in Tables 1–3.
TABLE 1 Physical characteristics of LUV of different compositions and their permeabilization by sticholysins
Lipid
Composition*
Diameter†
(nm)
SD/Mean‡
(%) Polarization§
Permeabilization¶
St I St II
Rmax (%) C50 (nM) Rmax (%) C50 (nM)
PC 69 28 0.25 0 — 0 —
PC/SM 1:1 94 22 0.36 96  5 9.7  1 98  2 8.7  1.4
SM 978 71 0.27 19  1 1.6  0.2 14.5  1 1.7  0.2
SM/PA 3:1 324 53 0.20 52  4 1  0.3 51  4 1.8  0.2
SM/PA 1:1 245 34 0.28 50  4 0.8  0.1 51  4 1.6  0.2
SM/PA 1:3 329 47 0.26 30  4 1.6  0.2 41  3 1.9  0.2
PA 168 33 0.22 0 — 0 —
PC/PA 3:1 394 56 0.26 0 — 0 —
PC/PA 1:1 227 52 0.28 7  2 10.9  0.2 13  2 9.7  0.6
PC/PA 1:3 206 40 0.29 0 — 0 —
PC/PS 1:1 96 25 0.22 5  2 8.5  0.2 3  1 16.2  0.9
*LUV composition with indication of molar ratio of mixtures.
†Average size determined by photon correlation spectroscopy.
‡Width of the distribution of vesicle size, i.e., the SD (as obtained from the polydispersity of the cumulant fit (Santos and Castanho, 1996)) expressed as
a percent of the mean value.
§Polarization (P) of DPH (Lakowicz, 1983). High polarization values imply higher viscosity, and vice versa, assuming that the fluorescence lifetime is
constant.
¶LUV permeabilization, as obtained in Fig. 2. Rmax is the maximal percentage of release at high toxin doses, whereas C50 is the toxin concentration necessary
to achieve 50% of Rmax.
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biologically significant, the role of negative lipids was in-
vestigated further.
Effects of different lipids on St I and St II
permeabilizing activity
To investigate whether the role of PA in the mechanism of
calcein release by actinoporins was peculiar or not, and
which were its basis, we compared it to other lipids (Fig. 5
and Table 3). These were all added at a concentration of 5
mol % to PC/SM (1:1) LUV, i.e., the concentration at which
PA had optimal effect. Because PA is negatively charged,
we first used a series of other acidic lipids that appear in the
composition of natural membranes: PG, PI, PS, and CL.
Interestingly, all negatively charged lipids had a strength-
ening effect, but only CL was as efficient as PA. PI, PS, and
PG had lower, albeit similar, effects. This was true both in
terms of C50 (Fig. 5 B) and of permeabilization rate (Fig. 5,
A and C), and to a similar extent for either St I or St II (see
Table 3). All these vesicles were very homogeneous in size,
with a diameter 110 nm and SD  20 nm (Table 3).
A possible explanation for the effects of negatively
charged lipids was that the negative surface potential they
create could attract the basic toxins. To control this, similar
experiments were performed including the zwitterionic
phospholipid PE or the positively charged lipid SA. Sur-
prisingly, these two lipids also produced a certain extent of
enhancement of St I and St II permeabilization (Fig. 5 and
Table 3). Maximal release in the presence of SA was lower;
however, although the size and dispersity of PE-containing
vesicles was normal, that of SA-containing LUV was larger,
240-nm diameter, and polydisperse, SD  100 nm (Table
3). In view of this, because PC/SM/SA LUV probably
contain also oligolamellar vesicles that do not permit a
complete calcein release, the enhancement observed with
SA was probably almost as significant as that with PE and
PS. Therefore, a role of a negative surface potential does not
seem to be purported.
This was further investigated using mixtures in which both
PA and SA were present. The stimulating effect of 1% of
negatively charged PA was not decreased by the simultaneous
presence of even twice as much positively charged SA, con-
firming that the generation of a negative surface potential was
not the boosting mechanism (Fig. 6 and Table 2).
Effects of ionic strength on the permeabilization
of vesicles with and without PA
To further assess whether an electrostatic interaction medi-
ated by surface charges was involved in actinoporin perme-
abilization, we studied the effects of ionic strength. It is
known, in fact, that increasing the ionic strength decreases
the electrostatic interactions via charge screening. To avoid
any possible influence of changes in vesicle shape due to
transmembrane salt gradients, in these experiments we kept
constant the total osmolarity of the solution by adding
suitable amounts of sucrose. Indeed, we observed that sti-
cholysin-induced calcein release from PC/SM/PA LUV (5
mol % PA) was influenced by the ionic strength (Fig. 7 A).
At all toxin doses, a certain decline of activity was observed
in increasing salt concentration above 200 mM. However,
these effects were not due to an electrostatic interaction
between the negative charge of PA and the positive charge
of the protein because uncharged vesicles, comprising only
zwitterionic lipids (PC and SM), displayed an even greater
decrease (Fig. 7 B). The results with St II are shown in Fig.
7; however, the same was observed also with St I. There-
TABLE 2 Physical characteristics and permeabilization parameters of SM/PC LUV containing different amounts of PA
PA* (%)
Diameter†
(nm)
SD
(%) P
Permeabilization
St I
n§
St II
n
Rmax
(%)
C50
nM
Kas‡
(s1 M1) Rmax (%)
C50
nM
Kas
(s1 M1)
0 94 22 0.36 95  5 9.7 1.8  0.4 1.1 98  2 8.7 0.8  0.4 1.5
0.2 110 17 0.38 86  4 7.0 2.6  0.4 1.1 89  3 7.3 0.8  0.1 1.4
0.5 115 24 0.40 80  3 5.6 4.4  0.6 1.0 84  5 7.1 1.2  0.6 1.4
1 113 18 0.32 81  3 5.0 6.9  0.5 0.8 83  3 6.0 3.2  0.7 1.7
5 112 20 0.35 78  2 2.2 18.6  4.2 1.1 77  3 1.9 18.1  4.1 2.1
10 131 17 0.38 80  2 2.4 13.7  5.0 1.0 80  2 3.3 10.5  3.5 1.8
1  SA¶ 1% 114 15 0.28 85  1 5.0 5.2  0.1 0.7 91.1  0.1 5.9 2.4  1.0 1.0
1  SA¶ 2% 119 21 0.32 92  4 4.0 8.3  0.3 0.8 90.6  0.5 4.4 2.3  0.5 1.3
*Molar amount of PA included in the composition.
†Average size, width of the distribution, polarization (P), Rmax, and C50 were all calculated as in Table 1. SD of C50 was typically within 5–7% of the mean
value.
‡Kas is the association rate constant of vesicle permeabilization, calculated for 6.4 nM St I or 8.8 nM St II, assuming n  1. Experiments were done in
quadruplicate.
§n is the power dependence of 1/	 on toxin dose (see Fig. 4 C).
¶In this case 1% of PA and the reported amount of SA were present.
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FIGURE 4 Effects of increasing PA content in PC/SM (1:1) LUVs on
the permeabilization by St I. (A) Kinetics of release at a constant dose of
St I (6.4 nM) with different percentage amounts of PA (as indicated). Lipid
concentration was always2 M, other conditions as in Fig. 2. The kinetic
were fitted to a single-exponential relaxation with time constant 	. (B)
Dose-dependence of calcein release induced by St I derived from the
steady state of kinetics like those in A. The maximal release obtained at
high toxin doses (Rmax) was slightly different with the different lipid
compositions (most probably because of changes in the small proportion of
oligolamellar vesicles remaining in the preparation). Therefore, the re-
ported release values (R%) have been normalized by dividing by Rmax. The
values of Rmax used are reported in Table 2. Points are average  SEM of
four determinations (except for control, which are average  SEM of 10
determinations). Solid lines have no theoretical meaning. (C) Double-
logarithmic concentration-dependence of the permeabilization rate 1/	. The
time constant 	 was obtained by the single-exponential fit of kinetic traces
like those shown in A. A linear regression provided the exponent of the
dose-dependence reported in Table 2.
FIGURE 5 Effects of including 5 mol % of different lipids into PC/SM
(1:1) LUVs on their permeabilization by St I. (A) Kinetics of release at a
constant dose of St I (6.4 nM) with different compositions. The kind of
lipid present at 5% in the LUV composition is indicated. With CL, which
has double charge and double mass compared to other acidic phospholip-
ids, the included molar amount was 2.5% and the molar ratio of negative
charges was 5%. Lipid concentration was always2 M, other conditions
as in Fig. 2. The kinetics were fitted to a single-exponential relaxation with
time constant 	. Here and in the other panels, curves with 5% PS and PG
were practically superimposed on that with 5% PI and were omitted for
clarity. (B) Dose-dependence of calcein release induced by St I derived
from the steady state of kinetics as in A. Also in this case the reported
release was normalized by dividing by Rmax. The values of Rmax used are
given in Table 3. Points are average  SEM of four determinations (or
average  SEM of 10 determinations for control). Solid lines have no
theoretical meaning. (C) Concentration-dependence of the permeabiliza-
tion rate 1/	, where 	 was obtained by the single-exponential fit of kinetic
traces like those in A. Linear regression of the double-logarithmic dose-
dependence provided the exponent n reported in Table 3.
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fore, the peculiar effects of PA (and CL) do not seem to
depend on their charge.
Effects of St I on the rate of lipid flip-flop
in the vesicles
We decided to further investigate the nature of the interac-
tion of St I with lipids by determining the transmembrane
movement of a fluorescent lipid included in the bilayer, by
the method of extraction of short chain lipids by BSA (Marx
et al., 2000). It was described, in fact, that some cytolysins
may increase the rate of transbilayer movement of lipid
molecules (Classen et al., 1987; Schneider et al., 1986).
That this is the case also for sticholysins is indicated by the
experiment reported in Fig. 8. The amount of labeled lipid
extracted by BSA in the external compartment was doubled
by the subsequent addition of St I. Instead, if St I was
present from the beginning, the amount available for BSA
extraction was already double that in the absence of St I,
even if St I itself did not effect any extraction. Because the
spontaneous flip-flop of lipids is a very slow event in the
absence of a specific enzymic flippase (t1/2 of days, see
Schneider et al., 1986), BSA is expected to extract only the
lipids in the outer layer. However, the addition of the
sticholysin also clearly promoted the accessibility of BSA to
the inner layer. Because BSA cannot permeate through the
St I pore and LUV are not broken by sticholysins at this
lipid-to-toxin ratio (Tejuca et al., 1996), this implies that St
I promotes the transfer of lipids from the inner to the outer
layer, similarly to other pore-forming peptides (Classen et
al., 1987; Schneider et al., 1986). The effect depends on the
dose of St I (Fig. 8, inset) and saturates at a total amount of
mobilized lipid that is 70% of that apparently made ac-
cessible by Tx100. This is probably a lower limit, because
Tx100 may affect the fluorescence of the label either di-
rectly or indirectly by diminishing the light scattering. In
addition, the incomplete mobilization observed may reflect,
at least in part, the presence of some oligolamellar struc-
tures, because in that case neither St I nor BSA can cross the
outer bilayer and all the label on the internal layers would
remain unextracted.
DISCUSSION
Inhibition of hemolytic activity (Fig. 1) and a direct perme-
abilization assay (Fig. 2) both indicate that sticholysins
interact preferentially with SM-containing membranes, as it
was consistently observed by all researchers in the field
(Kem, 1988; Macek, 1997; Macek et al., 1994; Turk, 1991).
The fact that pure SM membranes are better than PC/SM
membranes for inhibition of hemolysis, but not for perme-
abilization, is not a contradiction because the first experi-
ment was performed with SUV and the latter with LUV. We
have already shown that SUV of pure SM are better per-
meabilized than LUV of the same composition, and this was
attributed to the high packing of the headgroups in LUV,
which is not present in SUV (Tejuca et al., 1996). It was
supposed that a steric barrier did not allow adequate inter-
action of the protein with the SM headgroup, a preliminary
step for its binding and proper insertion into the bilayer. It
appears, in fact, that actinoporins recognize SM both at the
level of the headgroup, as indicated by the fact that SM
analogs with a modified phosphoric group are resistant to
these toxins (Meinardi et al., 1995), and by the ceramide
moiety, because the ganglioside GM1, with the same cer-
amide moiety as SM, could mimic its action (Macek et al.,
1994).
When different binary combinations of PC, SM, and PA
were compared for permeabilization by sticholysins, two
facts were clear: mixtures in general are more sensitive that
single lipids, and the presence of PA was a strong promoter
of toxin action. The fact that PA-containing vesicles were
more susceptible to sticholysins was analyzed in further
detail by incorporating small amounts of this lipid into
TABLE 3 Physical characteristics and permeabilization parameters of SM/PC (1:1) LUV containing 5% of different lipids
Added
Lipid
Diameter*
(nm)
SD
(%) P
Permeabilization
St I
n
St II
n
Rmax
(%)
C50
nM Kas
Rmax
(%)
C50
nM Kas
— 94 22 0.36 95  5 9.7 1.7  0.4 1.1 98  2 8.7 0.8  0.4 1.4
PA 112 20 0.35 78  2 2.3 18.6  4.2 1.0 77  2 3.9 18.1  4.1 2.1
CL 106 23 0.16 81  2 2.6 36.0  7.1 0.9 87  1 3.3 32.7  0.1 1.0
PG 108 21 0.20 82  2 5.3 9.4  2.9 1.5 83  1 7.2 2.6  0.5 2.0
PI 117 18 0.32 80  2 5.2 8.6  2.4 2.0 80  1 7.8 1.7  0.1 3.2
PS 116 20 0.32 79  2 5.5 7.2  3.0 1.8 78  2 7.8 1.0  0.6 1.5
PE 113 21 0.39 82  2 6.0 6.5  3.4 0.8 82  2 7.5 1.3  0.1 2.8
SA 239 43 0.34 54  2 5.5 0.9†  0.3 1.9 54  4 7.6 0.4†  0.1 1.6
*Average size, width of the distribution, polarization (P), Rmax, C50, Kas, and n were all calculated as in Tables 1 and 2. Experiments were done in
quadruplicate.
†This small value of the normalized association constant Kas originates from the larger size of the vesicles (see Eq. A5).
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susceptible vesicles composed of PC/SM (1:1). We ob-
served significant effects starting at very low PA concen-
trations, below 5%. One possible hypothesis was that the
negative surface potential generated by PA attracts the basic
cytolysins thus improving their membrane insertion. How-
FIGURE 6 Effects of co-including negatively and positively charged
lipids into PC/SM (1:1) LUVs on their permeabilization by St II. (A)
Kinetics of release at a constant dose of St II (8.8 nM) with different
compositions. Filled symbols are for control vesicles containing only PC
and SM in a 1:1 molar ratio. Empty symbols are for LUVs with the addition
of 1% negatively charged PA and 0, 1, or 2% positively charged SA (as
indicated). Lipid concentration was always 2 M, other conditions as in
Fig. 2. The kinetics were fitted to a single-exponential relaxation with time
constant 	. (B) Dose-dependence of calcein release induced by St II derived
from the steady state of kinetics as in A. Also in this case the reported
release was normalized by dividing by Rmax. The values of Rmax used are
given in Table 2. The outcome of one of two sets of experiments, giving
consistent results, is reported. Points of control are average  SEM of 10
determinations. Solid lines have no theoretical meaning. The linear regres-
sion of the double logarithmic dose-dependence of 1/	 was performed also
in this case and the derived exponent was included in Table 2.
FIGURE 7 Effect of ionic strength on St II permeabilization of PC/SM
(1:1) LUVs with or without 5 mol % PA. The buffer contained 1 mM
EDTA, 10 mM Tris-HCl buffering at pH 7.4, and the indicated concen-
tration of NaCl, while the total osmolarity was kept constant at 1277 mM
by the addition of sucrose. Lipid concentration was 2 M, whereas the
toxin dose was varied as indicated. Results for LUVs that did or did not
contain the negatively charged lipid are reported in A and B, respectively.
Points are average  SEM of four determinations in A and two in B.
Results with St I were completely consistent (not shown).
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ever, our results demonstrate that the surface potential gen-
erated by negatively charged lipid is not a determining
factor for pore formation by St I and St II. In fact, 1) other
lipids, even neutral or positively charged, induced enhanc-
ing effects; 2) there was no inhibitory effect of increased
ionic strength that could be ascribed to screening of the
surface potential; and 3) co-inclusion with PA of even twice
as much positively charged SA did not decrease the boost-
ing effect. With regard to the second point, i.e., the inhibi-
tory effect of high ionic strength with or without PA, it
could either be related to a protein conformational change
induced by high ionic strength, rendering the cytolysin less
competent to permeabilize the LUV, or to a strengthening of
the hydrophobic forces within the protein, preventing a
conformational change necessary for lipid binding, which
conceivably implies the exposure of a normally hidden
hydrophobic patch.
When different lipids were compared, all as 5% molar
inclusions in PC/SM LUV, it was observed that most of
them had strengthening effects on sticholysin action, i.e.,
reduction of C50 and increase of association constant; how-
ever, PA and CL elicited the strongest effects (Fig. 5 and
Table 3). This action is poorly related to the effects of these
lipid components on membrane viscosity, as indicated by
comparison with the measured DPH polarization (Tables
1–3). For example, PA didn’t change LUV viscosity,
whereas CL strongly decreased it, but both had the same
strong boosting effect on pore formation; similarly, PE
increased LUV viscosity, whereas PG markedly decreased
it, yet they elicited a very similar stimulation of sticholysin
action, lower than that of PA and CL (Table 3). Interest-
ingly, among the lipids tried, PA and CL are the strongest
inducers of negative curvature in the bilayer (Cullis and de
Kruijff, 1979; Farren et al., 1983; Seddon, 1990; Seddon et
al., 1983), and this property might be relevant. In fact, it was
recently suggested that the opening of some toxin channel
might be accompanied by the formation of a toroidal lipid
pore surrounding the toxin structure (Epand, 1998). In such
a toroidal arrangement, exemplified in Fig. 9, a positive
curvature is observed perpendicular to the plane of the
membrane, but a negative curvature is present in the plane
of the membrane all around the pore. Therefore, it is pos-
sible that the presence of minor amounts of lipids that favor
FIGURE 8 Effects of St I on the rate of transmembrane movement of a
fluorescent lipid. PC/SM (1:1) LUVs were prepared with the inclusion of
0.25% of a short-chain fluorescent lipid (P-C6-NBD-PC), and the NBD
fluorescence was measured at ex 470 nm, em 530 nm (lipid 125 M). At
the time indicated by the empty arrowhead either St I (upper dashed trace)
or BSA (lower continuous trace) was added in the external compartment at
a concentration of 0.42 and 5.8 M, respectively. BSA, but not St I (lower
versus upper trace), caused a substantial decrease of the fluorescence due
to the quenching of the extracted lipid (Marx et al., 2000). Subsequent
addition of St I (0.42 M) to toxin-free vesicles (arrow, lower trace),
induced a further decrease of the fluorescence of an amount equivalent to
the initial decay. Conversely, addition of BSA (5.8 M) to St I pre-treated
LUVs (arrow, upper trace), caused an immediate decrease of fluorescence
equivalent to the sum of the two steps observed when the reagents were
added in the opposite order. NBD fluorescence with completely solubilized
LUVs was determined adding 1 mM Tx100 (arrow). One of three equiv-
alent experiments is shown. Inset: Decrease of fluorescence induced by
BSA, at steady state, in the presence of different doses of St I. Values are
expressed as a percentage of the decrease observed in the presence of
Tx100. Other experimental conditions: buffer solution, 100 mM NaCl, 1
mM EDTA, and 10 mM Tris-HCl, pH 7.4
FIGURE 9 Cartoon of the lipid organization around the transmembrane
part of the pore formed by sticholysins. This is represented as a cylinder of
5 nm length (the thickness of the membrane) and 2 nm diameter (Tejuca
et al., 1996) built around 4–5 
-helices. Around the toxin channel a
toroidal lipid pore is formed. Lipids inducing positive curvature (conical
shape with headgroup at the base) are favored in the section of the lipid
torus perpendicular to the plane of the membrane (side view); lipids
inducing negative curvature (conical shape with headgroup at the tip, like
PA and CL) are favored in the central section parallel to the plane of the
membrane (top view). Lipids with cylindrical shape (e.g., PC and SM) are
preferred in the lamellar phase.
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this nonlamellar organization could also augment the effi-
ciency of toxin pore formation. Interestingly, it has been
found that in lipid membranes containing mixed cationic
and anionic lipids the order of propensity for the nonlamel-
lar phase is PA  CL  PG  PS (Lewis and McElhaney,
2000). This is practically the same order that we have
observed for the stimulation of pore formation (Fig. 5). In
our case, the positive charge, essential to compensate for the
electrostatic repulsion between negatively charged head-
groups, might be provided by basic residues present on the
transmembrane section of the toxin. Besides inducers of
negative curvature, such as the negatively charged lipids
above and PE (Cullis and de Kruijff, 1979; Seddon, 1990),
SA also has a strengthening effect (Fig. 5). SA, as a single
chain lipid, is normally an inducer of positive curvature
(Cullis and de Kruijff, 1979; Seddon, 1990) and as such
could help in stabilizing the profile of the toroidal pore
perpendicular to the membrane.
A similar toroidal pore has been proposed for the action
of the cationic antimicrobial peptide magainin (Matsuzaki,
1998, 1999) and experimental evidence has recently been
found (Yang et al., 2000). The magainin pore is lined by
seven copies of the molecule arranged in an 
-helical struc-
ture and has a diameter of 3.5 nm. The diameter of the
pore formed by sticholysins is 2.2 nm (De Los Rios et al.,
1998; Tejuca et al., 1996), and thus could involve only four
or five similar structures, in agreement with the fact that the
average stoichiometry of actinoporin channels is believed to
be a tetramer (Belmonte et al., 1993; De Los Rios et al.,
1999; Varanda and Finkelstein, 1980). A putative region of
the actinoporin that could be involved in crossing the mem-
brane is an amphipathic 
-helix located at the N-terminus
which was predicted, on the basis of the primary structures,
to be a conserved element of all actinoporins (Anderluh et
al., 1999b; Belmonte et al., 1994; Macek et al., 1994). This
helix has striking homology with bee venom melittin and
other cytolytic basic peptides of this family, which all adopt

-helical structure (Belmonte et al., 1994). It carries, at the
C-terminal side, a cluster of three positively charged resi-
dues (K-S-V-R-K) that could interact with acidic lipids.
The interaction of this N-terminal region with the lipid
membrane was demonstrated for equinatoxin II (Eqt II), one
of the best-studied actinoporins, by introducing single cys-
teins in this region which were then labeled with the lipid-
sensitive probe acrylodan (Anderluh et al., 1999a). Further-
more, the existence of an 
-helix at the N-terminus of Eqt
II has been now unequivocally established by crystallo-
graphic x-ray analysis (Gregor Anderluh, personal commu-
nication). In the same cystein scanning work (Anderluh et
al., 1999a), it was demonstrated that at least one other
portion of the molecule interacts with the lipid (i.e., a cluster
of tryptophan residues located around position 115), and
this can provide the basis for the higher affinity of actino-
porins to model and cell membranes as compared to most
small 
-helical cytotoxic peptides (Cornut et al., 1993).
Finally, it is worth mentioning that the diameter of the
lipid-surrounded aqueous pore that is observed in the in-
verse hexagonal lipid phase (HII), whose arrangement is
similar to the central part of the toroidal pore of Fig. 9, is
3–5 nm, depending on the lipid present (Seddon, 1990),
i.e., exactly in the range necessary for surrounding the
sticholysin pore.
One implication of the toroidal model is that each pore
behaves as a point of fusion of the inner lipid monolayer
with the outer one. This structure would clearly favor the
transbilayer movement of lipid molecules, which is other-
wise severely restricted in purely lipidic membranes. In-
deed, we have observed that St I induces mobilization of
inner layer lipids in a dose-dependent way (Fig. 8), thus
providing further evidence for the toroidal pore model. A
similar induction of transmembrane movement of lipid has
been observed also with other cytolytic peptides such as
gramicidin (Classen et al., 1987) and amphotericin B, but
also with a bacterial cytotoxin (Schneider et al., 1986). It is
possible that a similar mechanism of formation of nonla-
mellar phases was involved. In this regard it is worth
remembering that at least two other peptides have been
reported to promote the formation of a nonlamellar phase in
membranes, e.g., gramicidin S (Staudegger et al., 2000) and
alamethicin (Ionov et al., 2000). A model with some simi-
larities, called the “carpet model,” has been proposed as a
general mechanism of action of amphipathic 
-helical an-
timicrobial peptides (Oren and Shai, 1998). Such a model
also implies the formation of nonlamellar lipid structure;
however, in that case, the structure is much less ordered and
involves the presence of a high number of peptides. Our
model is also different from those used for large-molecular-
weight bacterial pore-forming toxins, which are essentially
of two types (Lacy and Stevens, 1998; Lesieur et al., 1997):
the -barrel model (whose prototype is the channel formed
by Staphylococcus aureus 
-toxin), and the 
-helical bun-
dle model (introduced for colicins and Bacillus thuringien-
sis -endotoxins). It is also different from the -barrel
model presented for B. thuringiensis cytocidal toxin (Le-
sieur et al., 1997; Li et al., 1996), a molecule of size similar
to the actinoporins, but it should be mentioned that this
model was recently questioned, and the involvement of two
toxin 
-helices was also invoked in that case (Gazit et al.,
1997), which could have some similarity with actinoporins.
This apparent uniqueness may reflect the fact that actinop-
orins are eukaryotic proteins and they are unrelated to any
other known protein, thus having the potential for a peculiar
mode of action.
APPENDIX
The kinetics of LUV permeabilization by sticholysins was analyzed in
terms of a simplified model, based on reaction rate theory, that we have
introduced earlier (Menestrina et al., 1989), with only minor modifications.
As already shown, sticholysins form pores in lipid vesicles through
which entrapped calcein can flow out (Tejuca et al., 1996). Because of the
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small dimensions of these vesicles the formation of just one channel, with
the conductance found in Tejuca et al. (1996), will release all the internal
calcein in a few milliseconds. Therefore, the rate-limiting event in our
experiments is the formation of pores and not the release of the marker.
Accordingly, we introduce a phenomenological reaction scheme for the
formation of oligomeric sticholysin pores:
Tf Tf · · · TfÇn
 L-|0
Kas
Kdis
P (A1)
where Tf and P represent free toxin and pores, respectively, and Kas, Kdis
the rate constants for association and dissociation. We will consider here
that the aggregation mechanism necessary to form the pore is sufficiently
represented by the experimentally determined exponent n, which does not
necessarily reflect the real number of monomers forming the pore. It
follows from scheme A1 that:
dP/dt KasTfnL KdisP (A2)
where quantities in square brackets are concentrations, and L indicates total
lipid available in the form of vesicles
We further assume that Kdis is negligibly small, on the basis of the fact
that binding to vesicles is virtually irreversible (as indicated by the inhi-
bition experiments in Fig. 1 and previously demonstrated (Tejuca et al.,
1996)). We can therefore rewrite Eq. A2 as:
d[P]/dt Kas[Tf]n[L] (A3)
[L] is related to the concentration of vesicles, [V], by
[L] [V] (A4)
where  is the average number of lipid molecules per vesicle, typically 105
in our experiments, and  is the fraction of lipid that is located in the outer
leaflet, 0.5.
In a normal experiment [Tf ] is 8 nM, while the total concentration
of vesicles, Vo, is 0.02 nM. Because permeabilization is well below
100%, it follows that some of the vesicles carry no channels and hence
that only very few of them, if any, carry more than one. Therefore, we
can reasonably assume that permeabilized vesicles contain only one
channel and thus that [Tf ] remains practically constant throughout the
reaction (first-order approximation). Accordingly, we introduce a new
rate constant:
K* Kas[Tf]n (A5)
If each permeabilized vesicle carries only one channel, we get the follow-
ing expression for the concentration of intact vesicles [V]:
[V] Vo P (A6)
Under these conditions Eq. A3 is easily integrated using Eqs. A4–A6 to
obtain
[V] Vo exp(t/	) (A7)
where 	 is an apparent time constant for the rate of disappearing of intact
vesicles related to K* by
K* 1/	 (A8)
For the total fluorescence F, our observable, we have that
F FoVo [V] FoVo1 expt/	)) (A9)
where Fo is the contribution to fluorescence of the content released by one
mole of vesicles. Fitting Eq. A9 to the time course of sticholysin-induced
fluorescence increase, we estimated the time constant 	 and from this the
association constant:
Kas 1/	Tf]n) (A10)
which is reported in Tables 2 and 3 together with the exponent n.
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